Intangible Assets

3 Months Ended

Mar. 31, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

The Company’s amortizable and unamortizable intangible assets at March 31, 2013 and December 31, 2012 are as follows:



	Cost				Accumulated Amortization
	March 31, 2013		December 31, 2012		March 31, 2013		December 31, 2012
Amortizable intangible assets:
Patents	$	14	$	14	$	8	$	8
Licenses	47		47		18		17
Customer relationships	249		255		65		61
Technical knowledge	48		48		16		15
Other	29		29		22		22
Total amortizable intangible assets	$	387	$	393	$	129	$	123
Unamortizable intangible assets:
Goodwill	$	701	$	717	$	26	$	26
Trademarks and trade names	20		20		8		8
Total unamortizable intangible assets	$	721	$	737	$	34	$	34

The Company recorded amortization expense of $7 for the three months ended March 31, 2013 and 2012, respectively, related to amortizable intangible assets. Amortizable intangible assets are amortized over their estimated useful lives, which range from one to twenty years, using the straight-line method. The Company expects to record annual amortization expense for all existing intangible assets in a range from approximately $21 to $26 from 2013 through 2017.

The change in net goodwill for the three months ended March 31, 2013 is as follows:




Balance at December 31, 2012	$	691
Acquisitions	(1		)
Impact of foreign currency exchange rates	(15		)
Balance at March 31, 2013	$	675

Current period acquisition activity related to the finalization of purchase accounting for BioReliance and Research Organics, which were acquired in January 2012 and March 2012, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details